Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemiaLaura Z. Rassenti, Thomas J. Kipps, Michael R. Grever et al.|Blood|2008Cited by 320
Use of IGHV3–21 in chronic lymphocytic leukemia is associated with high-risk disease and reflects antigen-driven, post–germinal center leukemogenic selectionEmanuela M. Ghia, Thomas J. Kipps, Sonia Jain et al.|Blood|2008Cited by 71